Attendee search 

For small and mid-size pharmaceutical companies, pharmBD is a "boutique-style" life sciences business development firm that offers customized expertise and services at all level of the deal making process. 

Adare Pharmaceutical Technologies (PT) is the specialty CDMO business unit of Adare, a global specialty pharmaceutical company. A science-driven provider of dosage form solutions for the healthcare industry – with expertise in taste masking and customized drug release – Adare PT is a leading partner to pharmaceutical companies across branded, specialty, 505b2, generic and OTC segments. With over 30 years of proven legacy, Adare PT focuses on oral dosage forms for small molecules across all therapeutic areas. To learn more, email us at BusDevROW@adarepharma.com.

Dr. M. Newzella GmbH is an international personnel and business consulting company active within the fields of pharmaceuticals and health care and specializing in the areas of Executive Search, Merger & Acquisition and Product & Licensing.

Thanks to its 35 years of branch experience, Dr. Newzella Consulting has built up an extensive international network of excellent business contacts and has far-reaching knowledge of both companies and markets to supports its clients with individual, flexible and high performance services.

Dr. M. Newzella GmbH is an international personnel and business consulting company active within the fields of pharmaceuticals and health care and specializing in the areas of Executive Search, Merger & Acquisition and Product & Licensing.

Thanks to its 35 years of branch experience, Dr. Newzella Consulting has built up an extensive international network of excellent business contacts and has far-reaching knowledge of both companies and markets to supports its clients with individual, flexible and high performance services.

Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, OTC and biosimilar products around the world.

A unique portfolio of high-quality and difficult-to-make products fuels our targeted growth strategy.

The company has commercial operations in 35 countries with 2,800 employees and operates five manufacturing and development hubs in the U.S., Romania, Korea and Taiwan.

Alvogen's product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, Women Health, neurology and gastroenterology, in addition to a fast-growing portfolio of biosimilars and OTC products.